NASDAQ
70.50USD
-0.25 (-0.35%)
We have scored 3 news catalysts on Metsera, Inc. (MTSR) over the past 12 months. The biggest single-day move next to one of them came Nov 10, 2025, when MTSR closed −14.8%: “5 Things to Know Before the Stock Market Opens”. Coverage across the window leans positive (average ticker sentiment +0.27). Most of the impact sits in sector healthcare and sector consumer.
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
7.4B
P/E
—
EPS
—
Beta
1.70
52W range
12.3-83.8599
Day range
70.13–70.76
Open
70.74
Prev close
70.75
Volume
27.9M
Avg volume
3.5M
Dividend
0.00
IPO
2025-01-31
Metsera, Inc. operates as a clinical-stage biotechnology firm, specializing in crafting both injectable and oral nutrient-stimulated hormone analog peptides. These therapeutic compounds are primarily aimed at addressing obesity, overweight conditions, and associated health issues. Its developmental pipeline features MET-097i and MET-233i, both under investigation for treating obesity and overweight patients. Furthermore, Metsera is advancing a potential combination therapy involving MET-233i and MET-097i. The company is also progressing additional drug candidates, including MET-002, MET-224o, MET-067i, and MET-034i, all of which target disorders such as diabetes and obesity. Founded in 2022, Metsera, Inc. maintains its corporate headquarters in New York, New York.
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about Metsera, Inc. — not a sector bucket. Click an edge to see the articles that established the link.
Suppliers, customers, partners and competitors of Metsera, Inc., taken from what the news actually said about them rather than from a sector bucket. The count is how many articles established each link.
Latest scored catalyst for MTSR: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
